PPARA and fatty liver disease: Additionally, a recent investigation of the effects of intermittent fasting on fatty liver disease in mice utilized combined proteome, transcriptome, and metabolome analyses to identify that peroxisome-proliferator-activated receptor alpha (PPARα) and glucocorticoid-signaling-induced PCK1 act co-operatively as hepatic executors of the fasting response [22].